logo
Share SHARE
FONT-SIZE Plus   Neg

Covidien Agrees To Buy Israeli Medical Device Maker

U.S. medical device maker Covidien (COV) has reached a definitive agreement to acquire Super-Dimension, the Israeli manufacturer of pulmonary devices. The purchase price for the deal is nearly $300 million, with some future payments possible, contingent on the performance of the company.

Super-Dimension's i·main product is its Logic System, which uses Electromagnetic Navigation Bronchoscopy. This high-tech method of navigation allows health professionals access to lesions deep in the lungs as well as in mediastinal lymph nodes.

The acquisition may close in the second calendar quarter of 2012.

Assuming a second calendar quarter 2012 closing, Covidien does not anticipate this transaction to have a material impact on its fiscal 2012 sales. Upon the close of the transation, Covidien would report the superDimension business in the Endomechanical product line within the Medical Devices segment.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
About nine-tenths of the world's sea birds are likely to have consumed pieces of plastic which continue to remain in their guts, a study shows. Automakers reported some mixed U.S. sales for August, marked by fewer working days and a delayed Labor Day, even as the month was largely bullish, spurred by lower interest rates, cheaper gas, and some strong employment data that buoyed consumer confidence. Bank of Nova Scotia or otherwise known as Scotiabank, Friday reported lower net profit for the third quarter, in the absence of a year-ago gain. Earnings per share, however, came in line with the Street view. Further, the company said it raised its quarterly dividend by 2 cents.
comments powered by Disqus
Follow RTT